Latham & Watkins Advises Bio-Rad Laboratories in US$200 Million Credit Facility

Bio-Rad Laboratories, Inc. has entered into a credit agreement for up to US$200 million on a revolving basis, including up to US$25 million of letters of credit. Borrowings under the revolving credit agreement will be used to make acquisitions, for working capital and for other general corporate purposes. Wells Fargo Bank, National Association is the administrative agent under the facility for a syndicate of lenders.

Latham & Watkins LLP represented Bio-Rad Laboratories, Inc. in the transaction with a finance team led by Washington, D.C. partner Jennifer Kent, with associate Lindsay Kenney.